The RNA inhibitor olpasiran significantly reduces a type of "bad cholesterol" that's associated with a high risk of ...
Researchers from Heidelberg University, Heidelberg University Hospital (UKHD) and Heidelberg Institute for Theoretical ...
Hosted on MSN1h
Aclaris Therapeutics Unveils Promising Data on ATI-2138, a Novel Dual ITK/JAK3 InhibitorAclaris Therapeutics, Inc. (NASDAQ: ACRS) has announced significant findings about ATI-2138, a novel investigational drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback